Gynov draws attention to common health condition in women, promotes supplement remedy

21 Oct 2022 --- Polycystic Ovary Syndrome (PCOS) – a common life-long health condition that affects five million women in the US – is receiving attention from the French health brand Gynov. Its Gynositol supplement provides women with an effective and safe supplement to address the underlying reason for the condition – nutritional deficiencies.

“PCOS affects 15 to 20% of women around the world. It is a major endocrine disorder, the number one cause of women’s infertility and connected to insulin resistance and obesity. It leads to symptoms that include ovulatory and menstrual irregularity, biological or clinical hyperandrogenism and ovary cysts,” says Pierre-Yves Mousset, co-founder and CEO at Gynov.

“The condition is associated with a urinary leak of inositols, mandatory molecules for the proper functioning of cells. Among those, the most fundamental element is Myo-inositol. As a result of this observation, we’ve also clinically proven that Myo-inositol supplementation significantly improves the pathology.”

“This is important since no specific treatment is available. That’s why we created Gynositol, to help women manage PCOS naturally and effectively.”

Two necessary ingredients
The supplement contains Myo-inositol and a bioactive form of B9 known as folate – 5-MTHF. This is a crucial nutrient for cell development and avoidance of neural tube closure defects during pregnancy. 

According to the company, the two ingredients found in Gynositol are necessary for female health. The two ingredients are described as essential for female health. According to the brand, Gynositol is backed by research and clean manufacturing methods and may help women manage severe and chronic health concerns.

The combination provides the active form of nutrient bypasses that the body needs to transform synthetic folic acid and avoid mutations in the gene coding for the MTHR enzyme responsible for this function. The company also notes that MTHFR mutations seem to be a risk factor for PCOS.

Gynov stresses that its product is only a supplement and not a replacement for medical treatment.

Women’s health awareness
In related news, UK-based companies recently launched a menopause-friendly symbol for retailers to use on store merchandising and online to guide women toward choosing the right product suitable when in menopause. A survey revealed that 90% of women wish for brands to be more inclusive while 91% said they lacked guidance from retailers on suitable products.

Meanwhile, on nutrition deficiency, a study published in Lancet Global Health revealed that two-thirds of women of reproductive age worldwide suffer from micronutrient and mineral deficiencies.

Gynov stresses that female health does not get enough attention despite PCOS and other female conditions being common and often treatable. It calls for more attention from the industry and increased general awareness to boost women’s well-being.

Edited by Beatrice Wihlander